Earnings Call: H1 2019

Jul 25, 2019

So good morning, everybody, and welcome to our RELX 2019 interim presentation. Thank you for coming. And for those of you who are listening to the webcast, thank you for joining us. I'm pleased to be able to say that RELX is continuing its positive overall development this year with good revenue and profit growth. This was also reflected during the period in our high cash flow conversion and our strong first half earnings growth. Adjusted cash flow conversion was 94%, a high level for the half year. And as you will have seen, adjusted earnings per share grew 12% in sterling and, as I said, a strong 8% in constant currencies. We've announced an increase in the interim dividend of 10% to 13.6p per share, and those shareholders on the Amsterdam Stock Exchange will receive an increase in the euro dividend of about 7%, depending, of course, on the precise exchange rate on the day. Our overall strategy of focusing on organic development, supplemented by selective acquisitions of targeted data, analytics and exhibitions assets is continuing to bear fruit across all four of our business areas. And as we enter the second half of twenty nineteen, key business trends for the year are in line with the full year of 2018. Thank you. I'll now hand over to Eric, who with Nick will take you through the first half results in some detail. Thank you, Antti. Good morning, everybody. Thank you for coming and for taking the time to be here today. As you've probably seen from our press release this morning, our positive financial performance continued in the first half of twenty nineteen with underlying revenue and adjusted operating profit growth across all four business areas. We also continued to make good progress on our strategic and operational priorities with our primary focus on the organic development of increasingly sophisticated analytics and decision tools and with recent acquisitions performing well. Underlying revenue growth was 3 months 3% for the 6 month period. Underlying adjusted operating profit growth was 4%. Earnings per share growth at constant currencies was 8%, and the interim dividend is up 10%. All four business areas again delivered underlying revenue growth as well as underlying operating profit growth. So let's look at the results for each business area. In STM, key business trends remained positive. Underlying revenue growth was 1% in the first half of twenty nineteen, following growth of 3% in the first half of the prior year and 2% in the full year 2018 as last year's favorable first half facing differences unwound in the second half. Good growth in electronic revenue was again partly offset by continued print declines. In primary research, we continued to enhance customer value by building out broader content sets, more sophisticated analytics and evolving our technology platforms. The number of article submissions and articles published in our subscription journals continued to grow strongly. The subscription renewal completion rate is in line with recent years, although in the prior year, we had a small customer revenue stream in the first half that we didn't have in the second half. Our open access publishing program, which now includes over 270 dedicated open access journals, in addition to sponsored article option almost all of our subscription journals, saw its growth rate accelerate as we continue to gain market share. Databases and tools continued to drive growth across market segments. Trint book revenues were down in the first half of twenty nineteen in a market environment that declined in line with historical trends. This is compared to an unusually favorable period of stable revenues in the first half of last year before a reversion to historical rates of decline in the second half of 2018. Going forward, our customer environment remains largely unchanged from recent years, and we expect another year of modest underlying revenue growth. Risk and Business Analytics grew 7% with strong growth across all key segments. In insurance, we continue to drive growth through the rollout of enhanced analytics, the extension of data sets and expansion in adjacent verticals. U. S. Market conditions were not quite as positive as in the prior year's first half. The market growth contribution was more in line with the second half of twenty eighteen and gradually improved through the period. In Business Services, strong growth was driven by further development of fraud prevention and risk management analytics. The U. S. And international market environment was broadly in line with historical trends. After a period of variability in transactional volumes, the growth rate returned to historical levels from the middle of the first half. Data Services was strong in all key verticals. The integration of last year's acquisitions, including ThreatMetrix and Safe Banking Systems, progressed in line with expectations and the businesses are performing well. Going forward, the fundamental growth drivers of risk and business analytics remain strong and we expect revenue growth trends for the full year to be in line with full year 2018. Legal underlying revenue growth of 2% was in line with the prior year. Underlying profit growth was ahead of underlying revenue growth with a margin increase reflecting organic process improvements as we enter the later stages of systems decommissioning. The market environment remains stable in the first half of twenty nineteen, and we saw continued growth in online revenues, partly offset by further print declines. The new platform rollout is nearing completion across all markets, enabling the release of broader datasets and further rollout of market leading legal analytics. And last week, we announced a joint venture with Knowable, a leading contract analytics provider. Going forward, trends in our major customer markets are unchanged and we expect another year of modest underlying revenue growth. Exhibitions underlying revenue growth was 5%, in line with the first half of the prior year. The lower underlying profit growth reflects cycling out effects. We continued to pursue organic growth opportunities, launching 25 new events and piloting and rolling out further data and analytics initiatives. Market conditions were good in Europe and the U. S. And remained strong in China. In Japan, local venue capacity constraints associated with the Tokyo Olympics started to have a negative impact in Q2 as previously communicated. In the first half, we completed the acquisition of Mac Brooks, a leading organizer of over 30 highly complementary events and integration is proceeding as planned. Going forward, temporary venue constraints and cycling effects aside, we expect underlying revenue growth trends to continue in line with the prior year. In addition to our organic development driven growth strategy, we continue to reshape our portfolio through selective acquisitions and disposals at a rate in line with recent years. In the first half of twenty nineteen, we completed 8 acquisitions for a total consideration of £246,000,000 and made a few minor disposals for £45,000,000 I will now hand over to Nick Luff, our CFO, who will talk you through our results in more detail. I'll be back afterwards for a quick wrap up and our usual Q and A. Thank you, Eric. Good morning, everyone. Let me start by giving a bit more detail on the financial highlights. As Eric said, we delivered underlying revenue growth of 3% in the first half. Growth in underlying adjusted operating profit was ahead of revenue growth at 4%, driving a 40 basis point margin improvement. Growth in earnings per share at constant currencies was 8%. Cash conversion was again strong at 94%. Leverage at the end of June was 2.6x, including leases and pensions, slightly higher than at the year end, which is usually the case given the first half weighting of the buyback and the dividend payments. The interim dividend is up 10% to 13.6p. Shareholders can still receive dividends in euros if they wish, with the exchange rate for the translation set about 2 weeks prior to the September payment date. In the first half, we deployed £400,000,000 in share buybacks, with a further £200,000,000 to be completed in the second half. Turning to the income statement. You can see the underlying revenue growth of 3%, with good growth in electronic and face to face revenues, partly offset by continued print revenue declines. Exhibition cycling and timing effects reduced revenue growth by 1% for the group, while portfolio effects had a neutral overall impact, giving constant currency revenue growth of 2%. The dollar was stronger against sterling compared to the first half of last year, resulting in reported revenue growth of 6%. Adjusted operating profit grew ahead of revenue growth at 4% on both an underlying and constant currency basis, reflecting the benefit of process innovation across the group and there being no portfolio drag in the first half of this year. Currency effects had a similar impact on profits as they did on revenue, adding 4% to take the sterling reported revenue growth and adjusted operating profit to 8%. The operating margin improved to 31.9%, forty basis points higher than in the prior period. Higher operating profits, a stable interest charge and a tax rate of 21.7%, in line with full year 2018, but lower than the first half of last year, delivered constant currency net profit, up 6%. The ongoing share buyback program reduced the average share count by around 2%, converting the 6% net profit growth to 8% growth in adjusted earnings per share at constant currencies. Currency also boosted EPS, of course, with adjusted earnings per share of sterling up 12 percent to 45.9p. Reported earnings per share was 39.9p, up 17%. Moving to the business areas. All 4 contributed to the overall underlying revenue growth performance, with Risk and Business Analytics and Exhibitions again delivering strong underlying growth. ThreatMetrix acquired in February last year is included within underlying growth for RMBA from the anniversary of the acquisition. SBS, the other notable acquisition from 2018, also in RMBA, will not be an underlying until the second half of this year. On a net basis, disposals in RMBA offset the revenue contributions from acquisitions prior to their 12 month anniversary, leaving constant currency growth the same as underlying growth. That was also true for SDM, while portfolio effects were negative for Legal. Exhibitions saw positive effect from acquisitions, notably Bank Brooks. Going the other way, cycling and timing effects reduced Exhibitions revenue growth by 6 percentage points. For the full year, we expect biennial event cycling to reduce Exhibitions revenue growth by around 5 percentage points. As we flagged previously, venue capacity constraints in Tokyo, which started to impact in the second quarter, will potentially reduce total Exhibitions underlying revenue growth by around 1 percentage point this year and next. With the weakness of the pound during the first half of the year, currency movements increased sterling reported revenues in all four business areas by between 2% 6%. Gross and underlying adjusted operating profit of 4% was driven by strong performances from RMBA and from Legal. STM and RMBA had underlying profit growth slightly ahead of revenue growth. Legal profit growth was again boosted by the benefits of system decommissioning. Exhibition's underlying profit growth of 1% reflects the negative impact of cycling and timing. Portfolio effects were a drag on profits for RMBA and for Legal. Acquisitions, mainly Mac Brooks, of course, gave a boost to Exhibitions profit. For the sterling profit figures, currency was a positive for all four business areas, most notably in RMBA, which is a high proportion of dollar revenues. The hedging program acted to smooth the currency impact in STM. Turning to margins. STM saw a slight increase while RMBA's margin was unchanged. Legal's margin was up 30 basis points as profits grew faster than revenues. The higher Exhibitions margin reflects the portfolio changes and the effects of cycling and timing. At the group level, the adjusted operating margin of 31.9% was 40 basis points higher than the prior first half, driven by underlying profit growth being ahead of underlying revenue growth. While we report in sterling, our 2 main revenue earning currencies are the U. S. Dollar and the euro. Most of our currency exposure is translational, but we do hedge some of the transactional exposure, most notably within SCM in their subscription business, which delays and smooths the impact of exchange rate movements. Exchange rates will, of course, move from today's levels, but sterling is currently weaker against the dollar and, to a lesser extent, against the euro compared to the averages for 2018. Current rates were sustained for the rest of the year, the currency benefit to sterling adjusted EPS growth for the full year compared to constant currencies will be a little bit less than we saw in the first half. Turning to cash flow. You can see CapEx was £171,000,000 equivalent to 4% of revenue. Total free cash flow increased to £794,000,000 reflecting increased operating profit and a strong cash conversion of 94%. And here's how we use that free cash flow. Acquisition consideration totaled $246,000,000 including most significantly, Mack Brooks and Exhibitions, while disposals aggregated £45,000,000 Dividend payments were £578,000,000 and the share buyback 400,000,000 euros Overall, that took net debt to £6,600,000,000 and leverage, which we calculate in U. S. Dollars, to 2.6 times, including leases and pensions, with the increase from 2.5x a year earlier entirely due to the increase in the pension deficit. As you can see, excluding leases and pensions, leverage was unchanged from a year earlier at 2.3 times. And with that, I will hand you back to Eric. Thank you, Dick. So just to summarize what we have covered this morning. During the first half of twenty nineteen, our positive financial performance continued and we made further strategic and operational progress. Going forward, the full year outlook is unchanged. As we enter the second half of twenty nineteen, key business trends for the full year are in line with the full year 2018. We remain confident that by continuing to execute on our strategy, we will deliver another year of underlying growth in revenue and an adjusted operating profit together with growth in adjusted earnings per share on a constant currency basis in 2019. And with that, I think we're ready to go to questions. Okay. So we'll start over here. Yeah. Hi. It's Nick Dempsey from Barclays. I've got 3, please. So just on Business Services, I wonder if you can help us understand a bit more what the variability was in the Q1. Just I mean, I understand what you've said, but maybe give us a bit more detail to understand whether that might recur at any point in the year? Second question, exhibition margins up decently in the first half. Nick explained that. But I'm just wondering, for the full year, will those timing effects and cycling effects all unwind? Or should we expect some margin improvement for Exhibitions for the full year? And last point, legal, you talked about entering the latter stages of systems decommissioning and the benefits of the margin. So this is a 2% organic growth business where margin improvements running out. Is it the sort of thing that Relic should own? Okay. I'm going to let Nick handle the second question on margin in exhibitions, but let me cover the first one and the question of ownership in legal. Business services in the risk division. For the Risk division as a whole, you know that almost 2 thirds of the business is transactional revenue streams, meaning they're often embedded inside customers or ongoing customers, but there's some variability in monthly billing. In business services, which include all the identity fraud management, risk management, risk assessment services for most financial and corporate customers. It's pretty similar. There you also have in addition some small batch sales here and there where people need to clean up files and do things that keep coming throughout the year. So there is a transactional component to that. That can vary a bit and has varied a bit over the last several years, continues to vary a bit. We saw last year that just towards the end of the year that period of variability started a bit. So if you look at it during the year now in retrospect, we can see that during the last quarter last year that variability started and had slightly lower contribution in the growth rates right at the end of last year in Q4 and that continued and started to recover a little bit in the Q1. But after the Q1 here, in the middle of the first half, was back to what we consider the solid continued traditional growth rates in that segment. And at this point, they're running at their traditional rate, which of course then is by definition ahead of where they started the year and is also ahead of where last year last year's second half last year ended, if you see what I'm saying. So that's where we are right now on business services. And you asked a question, has that happened before? There's always variability on a week to week, month to month basis there. So in any 3, 6 month period, it can vary a little bit. This happened to come over the end of the year basically and last a bit into the first quarter. Maybe I'll ask Nick to cover the margin question. So the ex question is margin question. As I said in the commentary for the first half, it is all about the actually in the odd years on margin when that particular set of shows, although overall in revenue terms as a cycling out year, we tend to do better on margin in odd years. We'll see where we get to at the full year for this year. But overall, for Exhibitions, as in all of our businesses, the objective is to keep cost growth below revenue growth, which, all other things being equal, will drive some margin improvement over time. That you do have to look through the cycling effects year on year to see that clearly in Exhibitions. And back to legal. As we enter the later stages of systems decommissioning, the gap between revenue growth and profit growth has been sort of 2% to 10% for the last few years on an organic basis has come down now to as you can see the first half I think was 2 and 5. Our objective here as we continue to run legal going forward is twofold. It is number 1, to accelerate the organic revenue growth in that business by adding more sophisticated analytics and higher value add decision tools to the legal industry, both the law firm service provider as well as corporate legal and government legal customers. And I think we have taken a lead in the industry in moving in that direction in devising tools that are may help higher value add add decision making. Our objective is to continue down that path and by adding higher value to customers, have them want more of our tools and therefore increase and accelerate our revenue growth. And also don't forget there that we have a print drag still in legal that right now is just below 15% of the business is print, But that is still a drag at this point in time and that will gradually fade over time. When it comes then to the margin progression, the margin progression on an underlying basis of course would have been higher than the 30 bps or so you see coming through over the last few years if you just had the 2.10, but that's because we had portfolio drag and other changes. As the portfolio drag should fade over time, the margin improvement is something that we still expect to continue to have over the last few years, but probably more in line with what you're seeing at this moment, right, than the kind of gaps you've seen in the past. So objective is to continue to have a gap between underlying revenue growth and underlying profit growth going forward. It's Sami from Exane. I have two questions, please. The first one, within Elsevier, can you comment on the organic revenue growth in the primary research part of the division? Was it consistent with previous years? Or has it slowed down or accelerated? And secondly, would you disclose the organic revenue growth rates of ThreatMetrix for the period, please? Thank you. Okay. Primary research so far, as you know this is an annual business and we're now sort of halfway through the year and things are done on an annual basis. The way we look at it are the key metrics in primary research to indicate where you are year to date compared to prior years and a few key metrics we look at. Number 1 is contract renewal completion rate. The contract renewal completion rate this year is in line with the last 2 years average, right? It's right on the last 2 year average. That small issue side with first, second half last year side. Then the other thing that we look at is, of course, new sales. If you look at new subscription sales for research as a whole, this year at the half year point, even though it's lumpy and it goes throughout the year, this year, we're slightly above the average of the last 2 years in new sales, right? There's a bit of fluctuation there because they're one off, but we're ahead of just marginally ahead of where we were on average over the last 2 years. The other metrics that we look at during the year is, of course, submission growth to our subscription journals, which continue to grow strongly. The articles published in subscription journals where we are growing well and growing ahead of market growth in subscription journals. And then, of course, on open access, both in terms of sponsored articles and in terms of author pays standalone dedicated journals, we have seen again submission growth grow strongly and actually accelerate already well into double digits, but accelerated in the first half of this year. And therefore, number of articles we published accelerated also in the double digits in the well into double digits in the first half, which means that we continue to gain share both in subscription volumes as well as in author based volumes. So you look at those are the metrics that during the year we look at renewals of subscriptions, new sales submissions. So if you look at it that way, the metrics that you would look at this year versus last couple of years is very much in line and on the same progress as the last couple of years. New sales and completion rates are in value terms, right, or in volume terms? Value terms. Thank you. Second question, organic growth rates in ThreatMetrix. Well ThreatMetrix, as you know, we bought during the first half last year and then integrated and started to slightly adjust the way we account for revenue versus cash accounting and so on in the corporation. But if you look at it right now, if you look at it right now today, the run rate in revenues today compared to a year ago, it's roughly 30% ahead of where it was a year ago, which I think is the right clean way to look at it. Right? So and you might recall that last year we said that when we took it over, when they were a smaller company at that time, the growth rate was about 40%, right, on a like for like basis we accounted for. And this is exactly what we had planned for and expected and what we built into our expectations as it gets bigger. So let's yes, so why don't we go over here then? Good morning. It's Adam Berlin from UBS. Thanks for taking the questions. I've got three questions. The first thing is you've guided for revenue trends for the full year to be in line with 2018. So if the first half was 3% for the group, that would imply the second half would be 5%. Can you just talk through the things that are going to drive the acceleration in the second half? Second question is on STM. You just made the point that value of renewals are the same, in line with historical trends. Have you had to be more flexible in your approach to negotiations to deliver that outcome? And the third question I had was, you talked about how articles being published is growing very strongly, and yet we're still seeing margin improvement in SDM despite the slowdown in revenue growth. What costs are you taking out of the business? Or are you going to be able to take out the business to keep STM margins where they are if that revenue growth continues to slow? Okay. So let's see. First question revenue growth. If you look at the first half revenue growth as disclosed which you can see and you look at the divisions, I know you all do this when either before or after you've been here, you can calculate that this what the range of outcomes would be and you can see that we're clearly above 3%, but not rounding to 4%. That's a mathematical thing, so that's not a news item. If you look at first half versus second half, you can see that our 2 largest divisions in the first half were a point lower on a full basis. And you've seen inside those divisions what the reasons for that were. And if you look at those, you can see that inside STM, the big swing factor compared to last year was the very unusually strong print book market and print book revenues in the first half that didn't exist in the second half. You can see the growth rate differential on print books in SGM in the second half last year was more than 10 percentage points worse than it was in the first half. So if you take that approach, you can see that the comp that was very strong and challenging in the first half is not at all that challenging going forward. Again, I don't know how to predict print book revenue streams 4 to 5 months out. We haven't figured out how to do that. So we don't know what will happen this coming November, December selling season, but I'm just explaining what happened last year versus where we are today. So if you look at the run rates in STM and in risk, as you could see that we had the unusual situation of the slow moving cycle in insurance market contribution, which tends to go in slower moving over several months based on how different carriers do price differentials and how shopping and switching behavior changes between the carriers, that tends to move in slow waves. That wave started to head down in the Q3 last year slowly and then bottomed out at the end of the year and then gradually throughout the 1st 6 months have come back up again. So the market contribution run rate at this point is exactly where it was on average last year. But last year had a very strong first half, right, and then came down. In business services, we talked about the difference between sort of slower at the end of last quarter, beginning on this quarter. So if you look at that in total, at this point in time, the current run rate in risk right now is higher than last year's second half total run rate. So that's why I'm saying that I'm not sure I would interpret it as acceleration. It's more a question of what happened to the comps. But that's a question of semantics and you can model it how you'd like. We haven't come up with a way to forecast the variability of transactional volumes in business services a few months out. And in insurance, there are trends and waves and new product pipeline. Those are very strong. So what we control in risk, the product pipeline, the product rollout, those continue very strongly. And you can see that in these charts that we put in the back and that we normally present every half year. So that's where we are today. 2nd question, renewals. In primary research and in science in general, we think of ourselves as a service provider. We want to provide a full range of products and services to our customers, and we want those products and services to be of higher quality than other major providers with better technology tools and be provided to them at an effective price to the customer that is better to them, lower to them than other major providers. That's our objective in all our customer interactions. What we do when we work with them is we don't talk about them in public. As you know, I don't comment on it in public. We engage directly with all these customers directly, directly individually or in groups. And we work with the combination of products and services that they request that they would like to have for us. Then we try to figure out a way to make sure that they get those in a way that's better for them, but at a lower price. Sometimes that's relatively straightforward to achieve, sometimes it's more complicated. Each customer is very different from the other. Individual countries and more importantly, individual institutions have different research intensity, different usage, different subject areas and so on. And we have to work with them to make sure that as we offer a broader and broader range of tools and more sophisticated analytical tools as well as broader and different content sets and different ways to publish. That is fully understood. We work through all scenarios and therefore come up with something that works well for them. As we now have a new CEO of the STM division that started in February, that is off to a very good start. She's, of course, engaging deeply with the customers, really already been out with many of the large ones. And she's very eager to take what she's learned from working with technology analytics decision tools in the other division as well as different content sets. And to take that knowledge to bring a sort of higher level of innovation and creativity to working with our customers. So do I believe that this will continue to evolve over the next few years, just like it has evolved over the last 10 or 20 years? Absolutely, I think it will continue to evolve. And I think she's in a very good position to do that. Margin Improvement in STM. The way we again think about our customer offering, if we're going to do what I just said, meaning higher quality, better technology, lower price, We need to continue to innovate, both in terms of how we put together content sets, how we operate our processes, the technologies we use and the efficiency of those processes in order to deliver that. We have continued to do that for many years already by leveraging technology and we will continue to do so. The way we think about applying modern analytics, artificial intelligence, technology decision tools to our customers' businesses to help them do better. We're also applying exactly that same thinking innovation approach to our own professionals to make sure that we can do more, get more value for a lower price than other people can get. And because we have larger scale in STM than any other provider and larger scale in technology and information than anybody else given that we operate across our 4 operating divisions, we believe that we can continue to lead the industry in process innovation and applying technology to process, so we should be able to continue to drive down the effective total unit cost of doing STM publishing for several more years going forward, just like we have literally over the last 20 years every single year. So we have great confidence that we should be able to continue to innovate and drive those unit costs down. I think that was that, okay? Hi. It's Matthew from Credit Suisse. Thank you for taking the questions. A couple of questions. The first thing is, you've got a new CEO in Elsevier. If you look at what's happened, I'm not going to ask you to comment on individual contracts. But if you look at what happened, there's been some win backs of previous situations. I won't enumerate all of them, but there's been some win backs. So it does look like there's more a definite change in attitude. What is that related to? Is that related to the new CEO, Elsevier? Or is that a decision that you've taken? And does that mean that we will be seeing from those people who've gone away, does that mean that they will embrace the newfound flexibility, too, over the next sort of few months? The second question is, could you just be a bit more precise on the insurance point? You talk about market conditions in U. S. Insurance being a bit softer, I guess, for the older products. Can you just be a bit more precise about what is actually happening? Is it less advertising by the U. S. Auto insurers? Is it less policy churn for some reason? It looks like U. S. Auto insurance prices have come down. Is it related to that? So if you could just be a little bit more precise about what's actually happened and then how it's changing and getting better that would be helpful. Yes. Okay. Our approach to working with our customers in Elsevier and STM has not changed. That is consistent with what I said before. We think of ourselves as a service provider, offer a full range of products and services. Our objective is to work with each customer individually and in-depth to make sure that we offer products and content sets of higher quality at lower effective prices and to do that in a way that's sustainable and attractive to our customers over several years. Of course, when you have a changeover in leadership, there's always a little bit of a transition period, which we've gone through. But the new CEO, as I said, has come into this full of energy, full of enthusiasm and interest in engaging directly with our customers and to innovate and use the knowledge she has from other division and from technology and from other content set to try to figure out how to continue to evolve the industry in a positive way both for the customers and for our STM division. And of course, when I say that we want to be a provider that provides content technology services at higher quality and lower price to our customers. We would ideally like to add to all research institutions in the world. We're here to help advance science and we would like to add to all of them. So if that means that there are some that have done less with us over the last couple of years or gradually done less or shifted away, of course, she's going to try to work with them going forward to try to gain to try to gain them back or to try to provide broader services with them in a way that's attractive to them. That's, of course, her objective and that's what she's going to continue to try to do. So I don't think it's a change in philosophy or strategy, but each individual has a different approach. And when you start to do something for a few years in your career, you're going to approach this with full of energy and desire to innovate and serve your customers. And I'm sure she will do that. Insurance, Just want to first repeat the way I talked about the market growth contribution, which is the way we think of the growth contribution from market activity for products older than 5 years, meaning it's not about the rollout and the timing of rollout of new products in the pipeline, but it's the market. And that's a definition that we use internally. We track all these metrics that combine to get sort of an activity measure for us, a value activity measure. It's not a number, right? So that's how we do it. And it has to do with all these different issues about which carriers offer what price differentials in which states and how do consumers react to those different price differentials and how do consumers shop and how many consumers switch when they shop relative to those price difference. And that creates an overall measure that we use. That is what has happened historically. And historically, that measure then keeps going in waves is probably more the right description than a fluctuate than a volatility. It goes in slow waves. Last year, we had a good first half there, a traditional on average, it's lined with a good performance we had over the last few years from the market contribution item. That then gradually started and slowed downward trend in the Q3 last year and that then bottomed out at the beginning of this year, at the end of last year, beginning of this year and then has gradually worked its way back up. So the market growth contribution at this point, at this point right now, we just had a conversation a couple of days ago, the current run rate is at the average contribution for the full year last year. But full year last year had a strong beginning and a weaker second half, right? So we are right now at the blended average run rate for last year. So that's why I want to make sure that when you ask why is it falling, I'm now back to a point where it's identical to last year. So I'm not sure I really want to try to explain why it was falling. But there are these kind of fluctuations we've seen in the past. They continue to happen. The market growth contribution, if you look over the last 5 to 10 years, they've gone in these waves up and down and so on. What I think is unusual this time around is that for the risk division as a whole is that when right when quarter this the Q1 this year. These are unrelated events, separate industries, different services and so on, but it's visible in terms of the overall growth rate because they happen to coincide. Normally, unrelated waves going at different times, they wouldn't normally have a high probability of doing that very often. But this kind of volatility or fluctuation that we saw in insurance, last time we saw that was probably 2 or 3 years ago, maybe for a half year period, we had something very similar. So that's where we are on the insurance growth. Okay. Thanks. It's Catherine Tait from Goldman Sachs. Three questions from me as well, please. The first one on STM. You talked about gaining share within Open Access. I wonder if you could quantify that a little bit more, give us a sense of where your market share in Open Access is today and how that compares to your market share in subscription journals? And then I suppose linked to that, can you give us a sense of where your average APC is across your OA journals? And yes, perhaps any sort of color around growth rates there? 2nd question on Legal. You talked about the new platform rollout. Can you give us a bit more color about specifically what does that enable you to do once that's rolled out versus perhaps your legacy platform? And maybe any update on new product rollouts that you've got coming through on that platform? And then finally, just on risk and Business Analytics. I think I'm right in saying that historically you've talked about that business very much being driven by volume growth. Can you give an update on in terms of whether or not still the case and whether or not you would consider using pricing as a lever too going forwards? Thank you. Yes. Okay. I'll try to cover most of those. I'm going to give Nick the one about legal platform in the middle there when we get there, but let me cover the others. So open access growth, when it comes to the exact definition of share, because in open access articles, there's such a full range from high quality index, high citation down to what we might seen as sort of typical average subscription journal quality down to things that are almost never cited and some people even criticized as predatory publishing and so on. The exact definition of how big the overall market is in your share, It's a little less precise, I think, and many people have different opinions on what should count as an open access article. So that's why we try not to articulate through a clear definition of what our share is, but we can tell you the growth rates that we have relative to growth rates that are in the market is the way we think about it. And again, by different definitions, you can come up with growth rates in the marketplace that are probably just a bit into double digits at this point. That's sort of what most people seem to say, even though again there are different definitions and different estimates. We are well into double digits, growing significantly faster than that. And that's how I know that therefore by definition we are gaining significant share. If our growth rate is significantly faster, at least double what the most of the measures are on the industry side. That's why I know that we're gaining share no matter which number you actually pick on share. And the same thing when we talked about subscription before, you can see the subscription article growth in the industry and you can see that we're above that and that's been the case for last several years. When it comes to APCs as you described them here, there's such a big mix difference here depending on which journals you launch and so on. We're now up to over 270 dedicated open access journals and they're launched at different times at different quality tiers and we launched them into the open windows in the market and the open windows in our offering, which means that given the size of this right now and the incredible growth activity we've had over the last 18 months to try to pick an add blended average between those is very difficult to make it meaningful. It's much easier to do it in an established segment like subscription, where you actually know our total revenue, the total number of articles published, total number of citations, total article downloaded and it's established and growing a few percentage points a year. So I would not what we do is we price every journal in each segment to market with our objective being again that in the medium term everything we do should be higher quality, lower price on a like for like basis. But we haven't even attempted to try to Yes. So we're well through the rollout of the new legal platform. Yes. So we're well through the rollout of the new legal platform, and we're now into that stage of decommissioning the older systems. I mean, that obviously is much more lightweight, much more modular. You can use the cloud. And that is you can see the benefit of that in terms of the operating cost, particularly as we go through this decommissioning. And there's still a couple of years left as you go through all the existing systems and turn them off. But more importantly, it actually also puts you in a better position for new product rollout. So it's much quicker and easier to add new analytical tools onto the existing platform, and the customers are much more easily to adopt them and adapt to them because we can just build them onto that new platform. So that's where we're seeing that benefit in terms of the rollout of new product. And the last question you had was risk. Risk has historically been driven by volume growth as you said. And is that still the case? Overall in risk in the traditional risk businesses, risk segments in the insurance business services are 2 large ones. It has always been driven by volume, not price. It continues to be driven by volume, not price. We have no intention of trying to make that a price driven industry. Again, we are trying to do what we're doing in our other segments, which we talked about before, which is higher value add, more sophisticated higher value add decision tools and analytics and lower price. And therefore, over time, the same question we had before on cost, we're applying to risk, which is that we should always strive to do everything we do internally better, faster, cheaper every single year. And that's the philosophy, which means that if you operate yourself better, faster, cheaper, you should not have any need to switch our approach to pricing. That's not on the card. Of course, we have different industry sub segments inside our data services group and so on, where it's not clear how you define volume. They're not volume driven. They're different types of sub segments, where it's a slightly different way to think about what volume is. And we're providing software tools or complete database access and other things. They operate slightly differently. Tom here from Citi. I had two questions, both, I'm afraid, on Elsevier. The first one, just to be specific, Matt sort of maybe alluded to it, but to be specific, with the Norwegian deal, which you successfully concluded, One of the people within the Unit consortium was quoted, I think, in the Times Higher Education sort of newspaper saying that they were surprised how quickly you came back to the negotiating table. There was a dispute and then it was resolved very, very quickly. So I was just wondering, can you just talk about the sort of general characteristics of that deal that meant it could be resolved quickly relative to some of the more drawn out disputes like California, like Germany? That was the first question. 2nd question was just once again around sort of some of these consortium disputes. I recognize there's lots of consortia. There is a very long list of clients. And so we're possibly in danger of over extrapolating the impact of them. But within a lot of these scientific communities, the Elsevier brand is associated with being sort of, intransigent, not willing to adapt, certainly relative to your competitors like Wiley and even Springer. So can you just talk about your approach to how Elsevier is perceived within the broader academic community? Are you just going to sort of brazen it out and hopefully in 2 years' time they'll recognize that actually you were right all along? Or is there remedial work need to be done in order to make sure that you're perceived well in the community? Thank you. Okay. That was it. Yes. The way we see it is again, I am not going to comment on individual customers as you know, but I can tell you in terms of approach. We have, as I said before, a new CEO of SGN, who is coming in full of energy and ready to engage with customers, eager to innovate, eager to come up with new solutions and eager to serve our customers with high quality, lower prices. Sometimes when you take that approach and you go into a customer, it's relatively straightforward to then figure out what value is and how to resolve it. In other places, it's much more complex, much more complicated, many more participants, many more subunits, many more sub segments of contents or tools and other things you're looking at. So it can take longer. We have to be patient and we will continue to be patient. I mean, we have been part of our SGM business, have been operating for close to 200 years now. And if we have the long term desire to be a high value, high quality service partner for our customers. We need to earn that by working our way through each customer 1 at a time. And that's exactly what the new CEO is ready to do and wants to do over the next few years. And of course, if we have, as you say, a challenging or difficult reputation or perception in certain segments with certain customers. That's of course not something we would be happy with or want to continue. So as a new leader of that market segment for us, that's of course going to be one of the things that she will continue to work on. So I think that answers your question. Yeah. Hi. It's Giussano Salati from Macquarie. Just a couple of questions, please. First, on open access gaining share, That should be a great concern for Elsevier because if you claim you're actually gaining share with a higher quality articles, those articles are coming out of subscription that are currently paid for. Right now, you are double billing on subscription, which contracts whose contracts typically last for 2, 3 years. And NAPC on the other side. Cooper is a good example. There was a 14% price decline on the contract over 4 years, which is in the press. You don't need to comment on that. I mean, you're clearly trending towards that kind of negotiations over time if you are yourself gaining share in higher quality articles with open access. And the second one, I'm puzzled. You say you haven't even attempted to calculate the APC across your open access articles. I think that is a pretty simple business the way I see it. It's volume, time, prices. So you are not in a position right now that you know what is the new world of open access in terms of economics because you don't know what pricing you are realizing in a very competitive and clearly quite a transformational move in the market? Okay. Very happy to answer those. First of all, open access gain of share. I also mentioned that we're gaining subscription market share. So we're not switching our Jira articles that we have already published into Open Access. We are publishing an increasing share of the subscription market at the same quality we had before if you read the public disclosures of quality and that's our objective. We have not captured fully the opportunity in Open Access over the last 2 years and we will continue to do that going forward. You made one completely incorrect statement, which I need to correct and that's the double billing comment. We have a complete nonnegotiable, no double dipping policy that we have on our Web site. I sat there for several years. We only price our subscription journals based on subscription quality and subscription volume. We only price our open access content based on open access content and price individually and by article and by journal. We do not double bill. That's very clear. When you talk about sorry, you then talked about, let me just make sure I look at it. Yes, you made a comment here on price decline. Again, I'm not going to talk about any individual customer, but you also have to be aware that the number of participants in and out side of one deal changes most of the time when we renew in any one country or any one institution or sets of institution, often it changes by very large numbers. And also the types of content sets that are included or not included in any deal normally changes and the number of tools and other services also changes. So I think you probably shouldn't take headline commentaries and say that these are like for like in most of our situations, right? Having said that, as I've said before, our objective is to offer higher quality content, higher volume, better tools at lower prices, and we're driving down our unit prices all the time. And our objective is to continue in that direction for a long period of time. So we hope that our customers should be able to see a relative value improvement in however they measure price per article, price per citation, price per something over time. That's our strategy. Let me address the last question on APC. We know exactly the APC chart every single article, every single journal, every single competitive sub segment. We are scientists, we are researchers, we are mathematicians, we are analysts, right? But when we're launching so many, in the last 6 months, we had over 25 new journals, right? And we're continuing at that rate to try to blend an average with some of them have introductory offers, some of them discounts, some of them starting point to try to blend them all and say that average has any meaning, I think is pushing it into an incredibly simplistic level that we don't really engage in. We compete segment by segment and journal by journal, sort of author by author and we try to price correctly in each one of those sub segments. We have 2,500 journals in total, over 2,000 of those are subscription And now over 270 are dedicated open access journals. And it's a competitive market, but its competition is not on some kind of global average or transition. The competition is segment by segment, journal by journal, author by author. And that's where we want to compete and offer higher quality and lower effective price. Down here. It's Patrick Wellington at Morgan Stanley. So Eric, if I were to characterize the shift from 2% growth to 1% growth in SDM in the first half as 80% books, 20% journals as the reason That would be would that be a fair representation? That's my first question. 2nd question, Plan S, whatever happened to that? Will it ever happen? Where do we stand in it? And maybe in a kind of related way, you've got a couple of customers who are quite large who you don't deal with at the moment, Germany, California, whatever. But again, not mentioning specific customers, can you tell us how researchers are getting on in those sort of institutions, the institutions who don't have direct access to the Elsevier stuff. Some of these people have been without for a year now. So what's happening with these people? And then the third one, a bit like the first question. By the end of the year, your trade your outlook statement suggests to me, because it's pretty much the same as it was at the start of the year, that normal service will be resumed at the end of the year: 2% growth in SDM, 4% growth for the group organically. Would you say that's a fair representation of your remarks? Okay. I'll make sure. You said H1 growth rate differentials. I think I've been pretty clear on what the main drivers are and how you calculate your percentages and so on. I'll item, which is the print book market differential first half versus second half last year and so on. The Plan S, it's one of several initiatives that we have seen over the last 10 maybe even 15 years at this point in different parts of the world in trying to advance a slight change in how to collect and disseminate scientific information and it has many different components to it. It's one of many. We continue to engage with all of them and to work with them to make sure that we can support our customers and provide services to that industry, whichever way it evolves. We don't have an opinion on how it should evolve. We have an opinion that we should continue to serve the industry really well at high quality and lower prices, How are researchers getting on in places where they don't have the full benefit of all the services they had before. Again, every situation is different depending on what they had before and what they have now and how they operate with others and which content set they were owning versus having temporary viewing rights and so on. So I should not comment on how they are getting on. I know that some of these in some of these locations and some of these institutes, they've done their own surveys. And some of those they made public and some of them they just comment on in public. And I just think that there's no question that for advancing science, people are better off when they have access immediate and easy access to the full range of high quality content sets and a full range of high quality tools that are available. Now exactly how and what the difference is, you'd have to ask the individual customers. But of course, our objective is to try to continue to serve them all well and to serve them with all the products and service that they would like to have from us and over time in a way that they see that value, but that they also we can also design something that gives them good value so that we will continue to serve them for a long period of time. That's our objective. Forecast for end of year. I think I've told you where we are right now compared to where we were a year ago. I've told you the differences between the first half last year, the first half this year and the differences. I think I've also told you that at where we are at this point in terms of all the metrics that drive our business segments, And I told you in risk, we're currently running at a revenue run rate that's already ahead of last year's second half average run rate. And also then we have acquisitions that are coming in as a larger piece in the second half. I don't know how to predict a few months out the transactional volumes in business services. I don't know how to predict the exact trends in the print book market in the November, December selling season this year. So I'm not going to try to make a forecast for how those will work in the future. But I can tell you that the current run rates would indicate that at this point where we are is a run rate that is significantly better for the company than the first half run rate would indicate because of the difficult comps that we had in the first half in print books in STM and in the growth market, growth contribution from prior year in insurance versus this and the dip in business services. Okay. Okay, thank you very much for coming and for taking the time to be here today.